Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.

Rheumatology (Oxford, England)

Volumn 48, Issue 11, 2009, Pages 1429-1434

  Soubrier, Martin ^a   Puéchal, Xavier ^a   Sibilia, Jean ^a   Mariette, Xavier ^a   Meyer, Olivier ^a   Combe, Bernarde ^a   Flipo, René Marc ^a   Mulleman, Denis ^a   Berenbaum, Francis ^a   Zarnitsky, Charles ^a   Schaeverbeke, Thierry ^a   Fardellone, Patrice ^a   Dougados, Maxime ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; METHOTREXATE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; DRUG ANTAGONISM; DRUG COMBINATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73349096059     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep261     Document Type: Article

References (0)